CAS Number: 121062-08-6
The maximum semaglutide dose depends on the brand and the FDA-approved use: Wegovy injection: 2.4 mg or 7.2 mg weekly (Wegovy HD, approved March 19, 2026)
To make sure of your safety and the safety of your child, some doctors recommend switching to non-oral methods such as IUD, implant, or injection
Stomach Paralysis The FDA has received reports of certain patients using semaglutide, encountering severe gastroparesis, commonly referred toas stomach paralysis. This condition leads to a significant slowing down of food digestion, potentially resulting in intense vomiting and nausea
Are you willing to tolerate more side effects for more results
Chen H, Lu Y, Shi S, Zhang Q, Cao X et al (2022) Design and development of a new glucagon-like peptide-1 receptor agonist to obtain high oral bioavailability